Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice

Bridging the bench to bedside gap: validation of a reverse-translated rodent continuous performance test using functional magnetic resonance imaging

(2013) Benjamin S. McKenna et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test

(2012) Jared W. Young et al.   BEHAVIOURAL BRAIN RESEARCH

Distinct muscarinic acetylcholine receptor subtypes mediate pre- and postsynaptic effects in rat neocortex

(2012) Sylvain Gigout et al.   BMC NEUROSCIENCE

Disentangling early sensory information processing deficits in schizophrenia

(2012) Anthony J. Rissling et al.   CLINICAL NEUROPHYSIOLOGY

Attentional Processing in C57BL/6J Mice Exposed to Developmental Vitamin D Deficiency

(2012) Lauren R. Harms et al.   PLoS One

Temporal and frontal cortical thickness associations with M100 auditory activity and attention in healthy controls and individuals with schizophrenia

(2012) J. Christopher Edgar et al.   SCHIZOPHRENIA RESEARCH

From antipsychotic to anti-schizophrenia drugs: role of animal models

(2012) Mark A. Geyer et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding

(2011) Jared W. Young et al.   BEHAVIOURAL BRAIN RESEARCH

Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania

(2011) Jared W Young et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Rats tested after a washout period from sub-chronic PCP administration exhibited impaired performance in the 5-Choice Continuous Performance Test (5C-CPT) when the attentional load was increased

(2011) Sam A. Barnes et al.   NEUROPHARMACOLOGY

Mouse pharmacological models of cognitive disruption relevant to schizophrenia

(2011) Jared W. Young et al.   NEUROPHARMACOLOGY

Lack of relationship between acoustic startle and cognitive variables in schizophrenia and control subjects

(2011) Wendy Hasenkamp et al.   PSYCHIATRY RESEARCH

D1 receptor activation improves vigilance in rats as measured by the 5-choice continuous performance test

(2011) Samuel A. Barnes et al.   PSYCHOPHARMACOLOGY

The scopolamine model as a pharmacodynamic marker in early drug development

(2011) Robert A. Lenz et al.   PSYCHOPHARMACOLOGY

Neurocognitive functioning in a group of offspring genetically at high-risk for schizophrenia in Eastern Turkey

(2010) Erol Ozan et al.   BRAIN RESEARCH BULLETIN

A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients

(2010) Leonhard Lennertz et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Decrements in Sustained Attention Across Trials in a Continuous Performance Test

(2010) Paul H. Lysaker et al.   JOURNAL OF NERVOUS AND MENTAL DISEASE

Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments

(2010) Martin Sarter et al.   NEUROPHARMACOLOGY

Assessing cognitive function in clinical trials of schizophrenia

(2010) Jennifer H. Barnett et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies

(2010) Inge Klinkenberg et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration

(2010) Jared W. Young et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Altered engagement of attention and default networks during target detection in schizophrenia

(2010) Wendy Hasenkamp et al.   SCHIZOPHRENIA RESEARCH

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

(2009) Jared W. Young et al.   PHARMACOLOGY & THERAPEUTICS

COMT Val158Met Polymorphism is Associated with Cognitive Flexibility in a Signal Discrimination Task in Schizophrenia

(2009) A. H. Neuhaus et al.   PHARMACOPSYCHIATRY

The 5-Choice Continuous Performance Test: Evidence for a Translational Test of Vigilance for Mice

(2009) Jared W. Young et al.   PLoS One

Functional Co-Primary Measures for Clinical Trials in Schizophrenia: Results From the MATRICS Psychometric and Standardization Study

(2008) Michael F. Green et al.   AMERICAN JOURNAL OF PSYCHIATRY

α7 nicotinic acetylcholine receptor activation ameliorates scopolamine-induced behavioural changes in a modified continuous Y-maze task in mice

(2008) John P. Redrobe et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Rats and humans paying attention: Cross-species task development for translational research.

(2008) Elise Demeter et al.   NEUROPSYCHOLOGY

Impact of the CATIE Findings on State Mental Health Policy

(2008) J. J. Parks et al.   PSYCHIATRIC SERVICES

CNTRICS Final Task Selection: Control of Attention

(2008) K. H. Nuechterlein et al.   SCHIZOPHRENIA BULLETIN

Selecting Paradigms From Cognitive Neuroscience for Translation into Use in Clinical Trials: Proceedings of the Third CNTRICS Meeting

(2008) D. M. Barch et al.   SCHIZOPHRENIA BULLETIN

Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching

(2007) Martha F. McCool et al.   NEUROBIOLOGY OF LEARNING AND MEMORY